Extensive portocava thrombosis revealing a primary antiphospholipid syndrome: A case report;Thrombose portocave extensive révélant un syndrome primaire des anticorps antiphospholipides : à propos d'un cas

Revue de Medecine Interne

Volumn 29, Issue 6, 2008, Pages 504-507

  Belkahla, N ^a   Maamouri, N ^a   Ouerghi, H ^a   Cheikh, I ^a   Hamida, S Ben ^a   Bouzid, H ^a   Ammar, A B ^a  

^a LA RABTA HOSPITAL   (Tunisia)

Author keywords

Anticardiolipin antibodies; Antiphospholipid antibodies; Budd Chiari syndrome; Primary antiphospholipid syndrome

Indexed keywords

ACETYLSALICYLIC ACID; CARDIOLIPIN ANTIBODY; HEPARIN; VITAMIN K GROUP;

ADULT; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; ASCITES; BUDD CHIARI SYNDROME; CASE REPORT; FATALITY; FEMALE; FIBERSCOPE ENDOSCOPY; HEMODIALYSIS; HEPATORENAL SYNDROME; HUMAN; LABORATORY TEST; LIVER FAILURE; LIVER TRANSPLANTATION; PHYSICAL EXAMINATION; PORTAL VEIN THROMBOSIS; RADIODENSITOMETRY;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BUDD-CHIARI SYNDROME; FATAL OUTCOME; FEMALE; HEPATORENAL SYNDROME; HUMANS; LIVER FAILURE; PORTAL VEIN; VENA CAVA, INFERIOR; VENOUS THROMBOSIS;

EID: 43849085145     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2008.01.005     Document Type: Article

References (22)

1. Forastiero R.R., Falcon C.R., and Maclouf J. Syndrome des antiphospholipides : de la reconnaissance des phospholipides à celle des « antiphospholipides protéines ». Hématologie 2 (1996) 203-210
2. Love P.E., and Santoro S.A. Antiphospholipid antibodies: anticardiolipin and lupus erythematous (SLE) and in non SLE disorders. Ann Intern Med 112 (1990) 682-698
3. Vianna J.L., Khamashta M.A., and Ordi-Ros J. Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients. Am J Med 96 (1994) 3-9
4. Pengo V., and Ruffati A. Laboratory diagnosis of antiphospholipid syndrome. Reumatismo 59 (2007) 187-191
5. Piette J.C., and Francès C. Quelle est la nature des lésions vasculaires du syndrome des anti phospholipides ?. Rev Med Interne 14 (1993) 476-480
6. Janssen H.L., Meinardi J.R., and Vleggar F.P. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case control study. Blood 96 (2000) 2364-2368
7. Asherson R.A. The catastrophic anti phospholipid syndrome. J Rheumatol 19 (1992) 508-512
8. Asherson R.A., Cervera R., de Groot P.G., Erkan D., Boffa M.C., Piette J.C., et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 12 (2003) 530-534
9. Denninger M.H., Chait Y., and Casadevall N. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 31 (2003) 587-591
10. Valla D.C. Hepatic vein thrombosis (Budd-Chiari syndrome). Semin Liver Dis 22 (2002) 5-14
11. Espinosa G., Font J., and Garcia-Pagan J.C. Budd-Chiari syndrome secondary to antiphospholipid syndrome: clinical and immunologic characteristics of 43 patients. Medicine 80 (2001) 345-354
12. Piette J.C., Cacoub P., and Wechsler B. Renal manifestations of the antiphospholipid syndrome. Semin Arthritis Rheum 23 (1994) 357-366
13. Khamashta M.A., Guadrado M.J., and Mujic F. The management of thrombosis in the antiphospholipid antibody syndrome. N Engl J Med 332 (1995) 993-997
14. Rosove M.H., and Brewer P.M. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 117 (1992) 303-308
15. Crowther M.A., Ginsberg J.S., and Julian J. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the anti phospholipid antibody syndrome. N Engl J Med 349 (2003) 1133-1138
16. Lim W., Crowther M.A., and Eikelboom J.W. Management of antiphospholipid antibody syndrome - A systematic review. JAMA 295 (2006) 1050-1057
17. Lockshin M.D., and Erkan D. Treatment of the anti phospholipid syndrome. N Engl Med 349 (2003) 1177-1179
18. Finazzi G., Marchioli R., Brancaccio V., Schinco P., Wisloff F., Musial J., et al. A randomized clinical trial of high-intensity warfarin vs conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost 3 (2005) 848-853
19. Tektonidou M.G., Ioannidis J.P., Boki K.A., Vlachoyiannopoulos P.G., and Moutsopoulos H.M. Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome. Q J Med 93 (2000) 523-530
20. Santamaria M.G., Agnelli G., Taliani M.R., Pandoni P., Moia M., Bazzan M., et al. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment. Thromb Res 116 (2005) 301-306
21. Loriot M.A., and Beaune P. La vitamine K époxyde réductase : du sang neuf dans les traitements anticoagulants oraux. Rev Med Interne 27 (2006) 979-982
22. Erkan D., Harrison M.J., Levy R., Peterson M., Petri M., Sammaritano L., et al. Arthritis Rheum 56 (2007) 2382-2391